Injured? Dial #WIN or #946 from your cellphone for your free consultation or call 1-800-LAW-NEED.
Call Us 24/7
( 1-800-529-6333 )
Click to Call 24/7

Quinapril Tablets USP Recalled Due to the Presence of a Carcinogen

January 03, 2023

According to an online news report published by, Lupin Pharmaceuticals announced a recall of certain lots of its Quinapril medications. The recall states that the blood pressure tablets have a potential impurity that is linked with cancer. According to a safety notice posted on the Food and Drug Administration's website, Lupin Pharmaceuticals began the voluntary recall of its blood pressure medications due to a potential nitrosamine impurity.

This Quinapril recall affects four specific lots of Quinapril - three lots of 40-milligram Quinapril Tablets USP (G100533, G100534, and G203071), and one lot of 20-milligram Quinapril Tablets USP (G102929). Patients, retailers, distributors, and wholesalers can locate the lot number on the bottle's side label.

Lupin Pharmaceuticals' recall notice states that recent testing uncovered the presence of N-Nitroso-Quinapril. The amount of N-Nitroso-Quinaprilhad was at levels "above the acceptable daily intake (ADI) level." Nitrosamines, which is a naturally occurring substances, can be found in certain foods and in water. According to the recall notice, consuming medications with traces of N-Nitroso-Quinapril can increase a person's risk of cancer. 

Lupin Pharmaceuticals stated that they are not aware of any illnesses connected to this recall reported. According to the company's recall notice, the recalled tablets were distributed throughout the United States and are prescribed to treat high blood pressure. 

People who are taking 40-milligram or 20-milligram Quinapril Tablets are advised to continue taking their Quinapril prescription medication and talk to their doctor about alternate medications. Lupin Pharmaceuticals is informing all distributors, wholesalers, pharmacy chains, supermarkets, and mail-order pharmacies about this urgent recall. Lupin Pharmaceuticals stated in its media release that these market suppliers must "immediately" stop dispersing the recalled Quinapril tablets. The company is also arranging for all the recalled batches to be returned.

Lupin Pharmaceuticals issued a voluntary recall of some blood pressure medication due to the potential presence of a nitrosamine impurity, according to a notice published on the Food and Drug Administration's (FDA) website.

Approximately 50% of U.S. adults (116 million) have been diagnosed with hypertension. Quinapril is one of the most prescribed high blood pressure medications in the United States with over one million prescriptions in 2020.

Have you or a loved one been harmed by recalled Quinapril tablets? Protect your legal rights by calling Montlick Injury Attorneys Nationwide, 24/7, at 1-800-LAW-NEED (1-800-529-6333), or simply dial #WIN (#946) from your mobile phone or use our Free 24-hour live chatOur Product Liability Lawyers are ready to listen to you, understand your situation, and advise you. View our reviews to read what our clients say about our commitment to exceptional service.

Sources: and

Category: Personal Injury

Please Note:
All information provided by our blogs is general in nature and should not be relied upon as legal advice. Consult a Montlick attorney for details about your unique situation.